During cancer progression, SMAD4 inactivation shifts TGFβ’s activity from tumor-suppressive to tumor-promoting by impairing its ability to trigger cell-cycle arrest and EMT-coupled apoptosis11,12. This evidence concerns the gene TGFB1 and neoplasm.